Stocks · Healthcare · Biotechnology
Abeona Therapeutics Inc. ABEO
$5.03 +0.40% Close, Oct 2, 2026 · NASDAQ · Market cap $286.7M
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $25.5M, up 6280.0% from a year earlier.
- Diluted EPS over the last four quarters was $-1.11, down 281.2% year over year.
- Operating margin widened to -327.6% from -18634.0% a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 1%
- EPS growth (TTM, YoY)Bottom 8%
- Revenue growth, 3-year CAGRTop 11%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 34%
- Gross marginBottom 41%
- Operating marginBottom 20%
- Accruals (lower is better)Bottom 9%
- Interest coverBottom 25%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 30%
- Free-cash-flow yieldBottom 18%
- EBITDA / enterprise valueBottom 22%
- Sales / enterprise valueBottom 32%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 43%
- 6-month returnBottom 47%
- 1-year return vs S&P 500Bottom 40%
- Distance from 52-week highBottom 47%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 45%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 34%
- Upside to consensus price targetTop 14%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 48%
- Maximum drawdown, 3 yearsTop 40%
- Beta vs S&P 500 (lower is better)Bottom 30%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Gross margin | -119.0% | 56.6% | ↑ |
| Operating margin | -18634.0% | -327.6% | ↑ |
| FCF margin | -17822.8% | -319.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6280.0% | — | Top 1% | |
| EPS growth (TTM, YoY) | -281.2% | — | Bottom 8% | |
| Gross margin | 56.6% | -119.0% | ↑ | Bottom 41% |
| Operating margin | -327.6% | -18634.0% | ↑ | Bottom 20% |
| Net margin | -246.4% | 14310.5% | ↓ | — |
| Free-cash-flow margin | -319.5% | -17822.8% | ↑ | — |
| Return on invested capital | -39.7% | — | Bottom 34% | |
| Revenue growth, 3-year CAGR | 60.3% | — | Top 11% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 7.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 34.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5773.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -25.3×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -3.06%
- Shareholder yield
- -3.06%
- Share count change, 1 year
- -14.4%
- Share count change, 3-year CAGR
- +46.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +6.0%
- Average 2-day reaction, last 8
- -0.9%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $17.67
- Target vs current price
- +251.3%
- Analysts with a rating
- 9
- Share rating Buy or Strong Buy
- 67%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | -51.1% | -14.9% | -17.8% | -26.5% | — |
| May 13, 2026 | +9.1% | +0.5% | -9.9% | -5.6% | +27.5% |
| Mar 17, 2026 | +2.9% | -3.8% | -10.7% | +4.8% | +8.3% |
| Nov 12, 2025 | +63.0% | +18.5% | +7.4% | +31.2% | +23.0% |
| Aug 11, 2025 | +538.5% | +0.3% | +13.9% | +7.0% | -23.6% |
| May 14, 2025 | +31.4% | -4.3% | +14.0% | +10.5% | +11.2% |
| Mar 20, 2025 | +31.0% | -1.2% | -4.0% | -6.7% | +18.5% |
| Nov 14, 2024 | -65.8% | -2.5% | -5.7% | -3.1% | -1.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.35 | -$0.23 | -51.1% | $11.4M |
| May 13, 2026 | -$0.30 | -$0.33 | +9.1% | $8.7M |
| Mar 17, 2026 | -$0.34 | -$0.35 | +2.9% | $5.4M |
| Nov 12, 2025 | -$0.10 | -$0.27 | +63.0% | — |
| Aug 11, 2025 | $1.71 | -$0.39 | +538.5% | $400,000 |
| May 14, 2025 | -$0.24 | -$0.35 | +31.4% | — |
| Mar 20, 2025 | -$0.24 | -$0.35 | +31.0% | — |
| Nov 14, 2024 | -$0.63 | -$0.38 | -65.8% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 9.81× | — | — | Bottom 32% |
| Free-cash-flow yield | -28.44% | — | — | Bottom 18% |
| Earnings yield | -21.97% | — | — | Bottom 30% |
P/E over the past five years
Range 4.3× – 11.8× since Jun 30, 2025. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -6.5%
- 200-day average slope (20 days)
- +1.1%
- Distance from 50-day average
- -16.1%
- Distance from 200-day average
- -9.4%
- RSI (14)
- 32.6
- Relative volume
- 0.83×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 54.4%
- Volatility vs own 5-year history
- 30th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.56
- Correlation with S&P 500
- 0.45
- Current drawdown from 1-year high
- -32.6%
- Maximum drawdown, 3 years
- -63.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 8, 2021 | Feb 24, 2023 | -97.4% | 515 days | Not yet recovered |
| Sep 25, 2020 | Sep 30, 2020 | -45.2% | 3 days | 73 days (Jan 14, 2021) |
| Jan 25, 2021 | Jan 29, 2021 | -18.0% | 4 days | 3 days (Feb 3, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $286.7M
- EPS, diluted (TTM)
- -$1.11
- Revenue (TTM)
- $25.5M
- 52-week range
- $4.00 – $7.65
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.0M | $1.4M | $3.5M | $0 | $5.8M |
| Gross profit | $3.0M | $964,000 | $1.9M | -$2.9M | $4.3M |
| Operating income | -$89.8M | -$50.9M | -$47.1M | -$64.2M | -$89.4M |
| Net income | -$84.9M | -$39.7M | -$54.2M | -$63.7M | $71.2M |
| EPS (diluted) | -$21.50 | -$5.53 | -$2.53 | -$1.55 | $1.01 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $400,000 | $0 | $5.4M | $8.7M | $11.4M |
| Net income | -$30.3M | -$9.3M | -$12.0M | $108.8M | -$5.2M | -$20.5M | -$17.1M | -$20.2M |
| EPS (diluted) | -$0.63 | -$0.23 | -$0.24 | $1.71 | -$0.10 | -$0.36 | -$0.30 | -$0.35 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$65.7M | -$43.5M | -$37.0M | -$56.0M | -$76.3M |
| Capital expenditure | -$4.2M | -$130,000 | -$331,000 | -$2.4M | -$8.0M |
| Free cash flow | -$69.8M | -$43.6M | -$37.3M | -$58.5M | -$84.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $24.0M | $47.0M | $37.2M | $85.6M | $26.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $146.8M
- Total assets
- $179.5M
- Total liabilities
- $51.4M
- Total debt
- $19.9M
- Net debt
- -$36.4M
- Shareholders’ equity
- $128.1M
As of Jun 30, 2026 (filed Aug 13, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Mar 31, 2000 | $0.59 | — |
Short interest
- Shares sold short
- 15,745,098
- Days to cover
- 11.99
- Change vs previous report
- +3.9%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 5, 2022
- 1-for-25
- Oct 24, 2014
- 1-for-50
- Jun 5, 2006
- 1-for-5
- Jun 18, 1998
- 1-for-20
- Jun 5, 1998
- 1-for-1